Introducing ATLASLearn more
Legal Opinion

AstraZeneca AB v. Aurobindo Pharma Ltd.

District Court, D. Delaware

Decided February 2, 2017No. C.A. No. 14-664-GMSPublishedCited by 8 opinions

1Opinion of the Court

MEMORANDUM

Gregory M. Sleet, UNITED STATES DISTRICT JUDGE

I. INTRODUCTION

In this consolidated patent infringement action, plaintiff AstraZeneca alleges that pharmaceutical products proposed by defendants Aurobindo Pharma Ltd., Auro-bindo Pharma U.S.A., Wockhardt Bio AG, Wochardt USA LLC, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sun Pharma Global FZE, Mylan Pharmaceuticals Inc., Watson Laboratories, Inc., and Actavis Laboratories FL, Inc. (collectively “Aurobindo”) infringe the asserted claims of U.S. Reissue Patent No. RE44,-186 (“RET86…

2Cases cited16 opinions

  1. Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
  2. KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
  3. Colorado v. New MexicoSupreme Court of the United States · 1984
  4. Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
  5. Octane Fitness, LLC v. ICON Health & Fitness, Inc.Supreme Court of the United States · 2014

11 more not listed; retrieve them via the Exa API.

3Cited by8 opinions

  1. Acorn Semi, LLC v. Samsung Electronics Co., Ltd.District Court, E.D. Texas · 2022
  2. Customedia Technologies, L.L.C. v. Dish Network CorporationDistrict Court, E.D. Texas · 2022
  3. Gigamon Inc. v. Apcon, Inc.District Court, E.D. Texas · 2022
  4. Implicit, LLC v. NETSCOUT Systems, Inc.District Court, E.D. Texas · 2020
  5. Indivior Inc. v. Mylan Technologies Inc.District Court, D. Delaware · 2020

3 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

View API DocsGet API Key

Powered by the Exa API